行动中的以患者为中心的护理:临床医生如何应对患者对避孕药副作用的不满
1University of California, Los Angeles, Los Angeles, CA, USA.
Journal of health and social behavior
|August 6, 2024
概括
在避孕中以患者为中心的护理往往优先考虑怀孕预防,而不是患者对不太有效的方法的偏好. 虽然提供者验证经验,但明确讨论避孕优先事项是罕见的,限制了患者真正的选择.
科学领域:
- 生殖健康 生殖健康
- 医学社会学 医学社会学
- 卫生沟通 卫生沟通
背景情况:
- 以患者为中心的护理是优质避孕服务的基石.
- 它在临床环境中的实际应用,特别是关于副作用的应用,仍在争论中.
- 了解以患者为中心的护理需要检查提供者与患者之间的互动.
研究的目的:
- 分析以患者为中心的护理作为避孕咨询中的互动现象.
- 调查提供者如何应对患者对荷尔蒙避孕药副作用的不满.
- 探索怀孕预防目标对避孕护理的影响.
主要方法:
- 对109个转录的生殖健康访问记录进行了定性分析.
- 检查医疗服务提供者的沟通策略,以应对患者报告的副作用.
- 在选择避孕方法时,专注于交互动态.
主要成果:
- 提供者对副作用不满的反应各不相同,从以患者为中心到专制.
- 以患者为中心的沟通往往验证了经验,但很少探索避孕优先事项.
- 提供者将患者引导到高效的荷尔蒙疗法,忽视了不太有效的选择.
结论:
- 以患者为中心的避孕护理往往受孕预防的首要目标所限制.
- 虽然提供者验证了患者的经验,但对避孕优先事项的明确讨论很少发生.
- 追求高效的方法可能会掩盖患者对替代避孕选择的偏好.
更多相关视频
03:30Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
1.4K
05:36Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
485
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Birth Control Methods
218
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
218
Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Drugs for Treatment of Constipation-Predominant IBS
149
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
149
